Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expanded antigen-experienced CD160+CD8+effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia
Najmeh Bozorgmehr, Isobel Okoye, Olaide Oyegbami, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 4, pp. e002189-e002189
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

The role of the immune microenvironment in bone, cartilage, and soft tissue regeneration: from mechanism to therapeutic opportunity
Yuan Xiong, Bobin Mi, Ze Lin, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 173
Metabolomic and immune alterations in long COVID patients with chronic fatigue syndrome
Suguru Saito, Shima Shahbaz, Xian Wu Luo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 33
Hematopoietic responses to SARS-CoV-2 infection
Shokrollah Elahi
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 53
Diverse immunological dysregulation, chronic inflammation, and impaired erythropoiesis in long COVID patients with chronic fatigue syndrome
Suguru Saito, Shima Shahbaz, Mohammed Osman, et al.
Journal of Autoimmunity (2024) Vol. 147, pp. 103267-103267
Open Access | Times Cited: 14
The Quality of SARS-CoV-2–Specific T Cell Functions Differs in Patients with Mild/Moderate versus Severe Disease, and T Cells Expressing Coinhibitory Receptors Are Highly Activated
Shima Shahbaz, Lai Xu, Wendy Sligl, et al.
The Journal of Immunology (2021) Vol. 207, Iss. 4, pp. 1099-1111
Closed Access | Times Cited: 55
Analysis of SARS-CoV-2 isolates, namely the Wuhan strain, Delta variant, and Omicron variant, identifies differential immune profiles
Shima Shahbaz, Najmeh Bozorgmehr, Julia Lu, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 21
Depletion of polyfunctional CD26highCD8+ T cells repertoire in chronic lymphocytic leukemia
Najmeh Bozorgmehr, Mark Hnatiuk, Anthea Peters, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 20
CD71+erythroid cells suppress T-cell effector functions and predict immunotherapy outcomes in patients with virus-associated solid tumors
Najmeh Bozorgmehr, Isobel Okoye, Siavash Mashhouri, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 5, pp. e006595-e006595
Open Access | Times Cited: 18
Potentiating the radiation-induced type I interferon anti-tumoral immune response by ATM inhibition in pancreatic cancer
Qiang Zhang, Long Jiang, Weiwei Wang, et al.
JCI Insight (2024)
Open Access | Times Cited: 5
Clonal succession after prolonged antiretroviral therapy rejuvenates CD8+ T cell responses against HIV-1
Eoghann White, Laura Papagno, Assia Samri, et al.
Nature Immunology (2024) Vol. 25, Iss. 9, pp. 1555-1564
Closed Access | Times Cited: 5
Polyfunctional CD8+CD226+RUNX2hi effector T cells are diminished in advanced stages of chronic lymphocytic leukemia
Maryam Rezaeifar, Shima Shahbaz, Anthea Peters, et al.
Molecular Oncology (2025)
Open Access
Streptococcus lutetiensis inhibits CD8+ IL17A+ TRM cells and leads to gastric cancer progression and poor prognosis
Huiyu Wang, Wenhua You, Zining Zhu, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemia
Annalisa Chiarenza, Gaia Vertillo Aluisio, Nunziatina Laura Parrinello, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment
David Van Morckhoven, Nathan Dubois, Dominique Bron, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemia
Audrey L. Smith, Sydney A. Skupa, Alexandria P. Eiken, et al.
JCI Insight (2024) Vol. 9, Iss. 10
Open Access | Times Cited: 3
Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer
Jiatao Liao, Hongyan Lai, Chang Liu, et al.
Cancer Science (2023) Vol. 114, Iss. 7, pp. 2774-2786
Open Access | Times Cited: 8
Differential Signature of the Microbiome and Neutrophils in the Oral Cavity of HIV-Infected Individuals
Eliana Perez Rosero, Samantha Heron, Juan Jovel, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 20
CD160 receptor in CLL: Current state and future avenues
Loubna Oumeslakht, Abdel-ilah Aziz, Armand Bensussan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
ADGRE5-centered Tsurv model in T cells recognizes responders to neoadjuvant cancer immunotherapy
Jian Li, Zhouwenli Meng, Zhengqi Cao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Targeting Dectin-1 and or VISTA enhances anti-tumor immunity in melanoma but not colorectal cancer model
Siavash Mashhouri, Amirhossein Rahmati, Ako Azimi, et al.
Cellular Oncology (2024) Vol. 47, Iss. 5, pp. 1735-1756
Open Access | Times Cited: 2
Elevated expression of interleukin 16 in chronic lymphocytic leukemia is associated with disease burden and abnormal immune microenvironment
Xun Wu, Jordan Thisdelle, Sen Hou, et al.
Leukemia Research (2023) Vol. 131, pp. 107315-107315
Closed Access | Times Cited: 6
CD160 protein as a new therapeutic target in a battle against autoimmune, infectious and lifestyle diseases. Analysis of the structure, interactions and functions
Marta Piotrowska, Marta Spodzieja, Katarzyna Kuncewicz, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113694-113694
Closed Access | Times Cited: 14
Transcriptomic profiling of peripheral blood cells in HPV‐associated carcinoma patients receiving combined valproic acid and avelumab
Najmeh Bozorgmehr, Hussain Syed, Siavash Mashhouri, et al.
Molecular Oncology (2023) Vol. 18, Iss. 5, pp. 1209-1230
Open Access | Times Cited: 5
Clinical implications of aberrant PD-1 expression for acute leukemia prognosis
Yanjie Ruan, Jiyu Wang, Qiuye Zhang, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 4
Immunological responses in SARS-CoV-2 and HIV co-infection versus SARS-CoV-2 mono-infection: case report of the interplay between SARS-CoV-2 and HIV
Shima Shahbaz, Wendy Sligl, Mohammed Osman, et al.
Allergy Asthma and Clinical Immunology (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top